Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 8:07 p.m.

    📋 Oncolytics Biotech Inc (ONCY) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 16:05:33

    Event Type: Clinical Trial Update

    Event Details:

    Oncolytics Biotech Inc (ONCY) Announces Clinical Trial Update Oncolytics Biotech Inc (ONCY) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: innovations, USPTO
    • Diseases/Conditions: pelareorep
    • Collaboration: the United States Patent and Trademark Office
    • Updated Timeline: Q4 2025, early Q3 2025

    🔬 Clinical Development Pipeline (Oncolytics Biotech Inc):

    Product Type Development Stage Therapeutic Area Source
    Chemotherapy DRUG Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Pelareorep DRUG Phase PHASE1 Anal Cancer Metastatic ClinicalTrials.gov
    mFOLFIRINOX Treatment Regimen DRUG Phase PHASE1 Anal Cancer Metastatic ClinicalTrials.gov
    Trifluridine Tipiracil DRUG Phase PHASE1 Anal Cancer Metastatic ClinicalTrials.gov
    Gemcitabine and nab-paclitaxel DRUG Phase PHASE1 Anal Cancer Metastatic ClinicalTrials.gov
    Atezolizumab DRUG Phase PHASE1 Anal Cancer Metastatic ClinicalTrials.gov
    REOLYSIN® BIOLOGICAL Phase PHASE2 Osteosarcoma ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE2 Metastatic Melanoma ClinicalTrials.gov
    Carboplatin DRUG Phase PHASE2 Metastatic Melanoma ClinicalTrials.gov
    REOLYSIN BIOLOGICAL Phase PHASE2 Metastatic Melanoma ClinicalTrials.gov
    Gemcitabine DRUG Phase PHASE2 Metastatic Pancreatic Adenocarcinoma ClinicalTrials.gov
    Placebo DRUG Phase PHASE3 Carcinoma, Squamous Cell of the Head and Neck ClinicalTrials.gov
    Cisplatin DRUG Phase PHASE1 Muscle-invasive Transitional Cell Carcinoma of the Bladder ClinicalTrials.gov
    Pembrolizumab DRUG Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    5-fluorouracil DRUG Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Leucovorin DRUG Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Irinotecan DRUG Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Lenalidomide or Pomalidomide DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Bevacizumab DRUG Phase PHASE1 KRAS Mutant Metastatic Colorectal Cancer ClinicalTrials.gov
    Fluorouracil (5-FU) DRUG Phase PHASE1 KRAS Mutant Metastatic Colorectal Cancer ClinicalTrials.gov
    Trastuzumab DRUG Phase EARLY_PHASE1 Breast Cancer ClinicalTrials.gov
    Letrozole DRUG Phase EARLY_PHASE1 Breast Cancer ClinicalTrials.gov
    Docetaxel and Prednisone DRUG Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    Docetaxel, Reolysin and Prednisone DRUG Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    Docetaxel DRUG Phase PHASE2 Non Small Cell Lung Cancer ClinicalTrials.gov
    Docetaxel and Reolysin DRUG Phase PHASE2 Non Small Cell Lung Cancer ClinicalTrials.gov
    Pemetrexed DRUG Phase PHASE2 Non Small Cell Lung Cancer ClinicalTrials.gov
    Pemetrexed and Reolysin (and safety run-in) DRUG Phase PHASE2 Non Small Cell Lung Cancer ClinicalTrials.gov
    Folfox plus Bevacizumab DRUG Phase PHASE2 Colorectal Cancer ClinicalTrials.gov
    Folfox plus Bevacizumab and reolysin DRUG Phase PHASE2 Colorectal Cancer ClinicalTrials.gov
    Wild-type Reovirus BIOLOGICAL Phase PHASE1 Recurrent Plasma Cell Myeloma ClinicalTrials.gov
    Pharmacological Study OTHER Phase PHASE1 Recurrent Plasma Cell Myeloma ClinicalTrials.gov
    Laboratory Biomarker Analysis OTHER Phase PHASE1 Recurrent Plasma Cell Myeloma ClinicalTrials.gov
    Dexamethasone DRUG Phase PHASE1 Recurrent Plasma Cell Myeloma ClinicalTrials.gov
    Bortezomib DRUG Phase PHASE1 Recurrent Plasma Cell Myeloma ClinicalTrials.gov
    Avelumab DRUG Phase PHASE2 Breast Cancer Metastatic ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Oncolytics Biotech Inc
    • Ticker Symbol: ONCY

Search

News categories